Cargando…
Why angiotensin converting enzyme inhibitors and angiotensin II receptor blockers are not prescribed in the management of hypertension among hemodialysis patients in India
| Autores principales: | , , |
|---|---|
| Formato: | Online Artículo Texto |
| Lenguaje: | English |
| Publicado: |
Medknow Publications & Media Pvt Ltd
2014
|
| Materias: | |
| Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4074698/ https://www.ncbi.nlm.nih.gov/pubmed/25031502 http://dx.doi.org/10.4103/0976-0105.134987 |
| _version_ | 1782323233842790400 |
|---|---|
| author | Mateti, Uday Venkat Nagappa, Anantha Naik Balkrishnan, Rajesh |
| author_facet | Mateti, Uday Venkat Nagappa, Anantha Naik Balkrishnan, Rajesh |
| author_sort | Mateti, Uday Venkat |
| collection | PubMed |
| description | |
| format | Online Article Text |
| id | pubmed-4074698 |
| institution | National Center for Biotechnology Information |
| language | English |
| publishDate | 2014 |
| publisher | Medknow Publications & Media Pvt Ltd |
| record_format | MEDLINE/PubMed |
| spelling | pubmed-40746982014-07-16 Why angiotensin converting enzyme inhibitors and angiotensin II receptor blockers are not prescribed in the management of hypertension among hemodialysis patients in India Mateti, Uday Venkat Nagappa, Anantha Naik Balkrishnan, Rajesh J Basic Clin Pharm Letter to Editor Medknow Publications & Media Pvt Ltd 2014-03 /pmc/articles/PMC4074698/ /pubmed/25031502 http://dx.doi.org/10.4103/0976-0105.134987 Text en Copyright: © Journal of Basic and Clinical Pharmacy http://creativecommons.org/licenses/by-nc-sa/3.0 This is an open-access article distributed under the terms of the Creative Commons Attribution-Noncommercial-Share Alike 3.0 Unported, which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited. |
| spellingShingle | Letter to Editor Mateti, Uday Venkat Nagappa, Anantha Naik Balkrishnan, Rajesh Why angiotensin converting enzyme inhibitors and angiotensin II receptor blockers are not prescribed in the management of hypertension among hemodialysis patients in India |
| title | Why angiotensin converting enzyme inhibitors and angiotensin II receptor blockers are not prescribed in the management of hypertension among hemodialysis patients in India |
| title_full | Why angiotensin converting enzyme inhibitors and angiotensin II receptor blockers are not prescribed in the management of hypertension among hemodialysis patients in India |
| title_fullStr | Why angiotensin converting enzyme inhibitors and angiotensin II receptor blockers are not prescribed in the management of hypertension among hemodialysis patients in India |
| title_full_unstemmed | Why angiotensin converting enzyme inhibitors and angiotensin II receptor blockers are not prescribed in the management of hypertension among hemodialysis patients in India |
| title_short | Why angiotensin converting enzyme inhibitors and angiotensin II receptor blockers are not prescribed in the management of hypertension among hemodialysis patients in India |
| title_sort | why angiotensin converting enzyme inhibitors and angiotensin ii receptor blockers are not prescribed in the management of hypertension among hemodialysis patients in india |
| topic | Letter to Editor |
| url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4074698/ https://www.ncbi.nlm.nih.gov/pubmed/25031502 http://dx.doi.org/10.4103/0976-0105.134987 |
| work_keys_str_mv | AT matetiudayvenkat whyangiotensinconvertingenzymeinhibitorsandangiotensiniireceptorblockersarenotprescribedinthemanagementofhypertensionamonghemodialysispatientsinindia AT nagappaananthanaik whyangiotensinconvertingenzymeinhibitorsandangiotensiniireceptorblockersarenotprescribedinthemanagementofhypertensionamonghemodialysispatientsinindia AT balkrishnanrajesh whyangiotensinconvertingenzymeinhibitorsandangiotensiniireceptorblockersarenotprescribedinthemanagementofhypertensionamonghemodialysispatientsinindia |